{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-pneumococcal/management/routine-vaccination-of-infants-adults-over-65-years-of-age/","result":{"pageContext":{"chapter":{"id":"b036915e-0e64-5fea-a247-9777822304b3","slug":"routine-vaccination-of-infants-adults-over-65-years-of-age","fullItemName":"Scenario: Routine vaccination of infants, and adults over 65 years of age","depth":2,"htmlHeader":"<!-- begin field 3c21125b-dc77-4eeb-8ea4-0e85c8c0d577 --><h2>Scenario: Routine pneumococcal vaccination</h2><!-- end field 3c21125b-dc77-4eeb-8ea4-0e85c8c0d577 -->","summary":"Covers the routine immunization of infants and people over the age of 65 years.","htmlStringContent":"<!-- begin item 889ab139-3b97-4ffc-a271-a88003dca599 --><!-- begin field 0a9e5dc3-edcf-403c-9701-acd900ae19e2 --><p>From age 2 months onwards.</p><!-- end field 0a9e5dc3-edcf-403c-9701-acd900ae19e2 --><!-- end item 889ab139-3b97-4ffc-a271-a88003dca599 -->","topic":{"id":"af89c4a4-b7c5-5032-9cab-157c542f213b","topicId":"667146c4-e374-494f-a050-b8976e5e7056","topicName":"Immunizations - pneumococcal","slug":"immunizations-pneumococcal","lastRevised":"Last revised in January 2021","chapters":[{"id":"c2a8d969-5d35-5185-b666-883786b066c5","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9db009c1-59ed-5d79-9446-33e54e1676c7","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"cf4adec7-88ef-5a0f-b072-53bd3049b260","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5459dd7c-ac40-5828-8bec-840fa7fca764","slug":"changes","fullItemName":"Changes"},{"id":"197178ce-11cd-52df-883c-419e06744dd4","slug":"update","fullItemName":"Update"}]},{"id":"95a44f6b-2987-5086-8656-ef21fcbbc28b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"006db835-5d01-5085-a6e1-ee57f7ca41c8","slug":"goals","fullItemName":"Goals"},{"id":"29af8dc8-13e9-56c4-a041-b00bbf320b1e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e7b32647-3434-5f3f-b8be-51203e3ebfee","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ebc71bdc-4766-5946-bb16-121b9da544f3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3daf6a12-bce0-53d4-a318-05cc49aab107","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4dce4bc5-1119-5c5d-9422-d275fc956a4e","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"002fbb60-3041-597d-9d3d-fc3a17068591","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"37c59838-49d0-51d5-8203-1eae848738c2","slug":"definition-of-pneumococcal-disease","fullItemName":"Definition of pneumococcal disease"},{"id":"aba9a3c5-f0f7-5e65-b369-1947461d0158","slug":"prevalence-of-pneumococcal-disease","fullItemName":"Prevalence of pneumococcal disease"},{"id":"9da9e662-ccc4-5bc4-bae8-eb3f0ec80b19","slug":"risk-factors-for-pneumococcal-disease","fullItemName":"Risk Factors for pneumococcal disease"},{"id":"492f20c5-5e03-51dc-9ccb-1994f3db1c35","slug":"pneumococcal-immunization","fullItemName":"Pneumococcal immunization"}]},{"id":"e183f01f-d538-542b-bc16-6f849966d1d2","fullItemName":"Management","slug":"management","subChapters":[{"id":"b036915e-0e64-5fea-a247-9777822304b3","slug":"routine-vaccination-of-infants-adults-over-65-years-of-age","fullItemName":"Scenario: Routine vaccination of infants, and adults over 65 years of age"},{"id":"8f83b7e0-d764-5bca-a03b-e549e24f402a","slug":"children-diagnosed-at-increased-risk-under-2-years-of-age","fullItemName":"Scenario: Children diagnosed at increased risk under 2 years of age"},{"id":"c9787edf-835f-54d9-9b86-b7c8695307ef","slug":"children-diagnosed-at-increased-risk-aged-2-5-years","fullItemName":"Scenario: Children diagnosed at increased risk aged 2-5 years"},{"id":"7f443a07-5081-5296-b56e-8b82550f8c52","slug":"children-over-5-years-of-age-adults-diagnosed-at-increased-risk","fullItemName":"Scenario: Children over 5 years of age and adults diagnosed at increased risk"}]},{"id":"f17e101b-7bea-59aa-9b9c-46924bbfdc2b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"871f5861-588e-57ef-9521-0a81e77d4583","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d0a50959-6448-5a18-8845-f75f5c40f388","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"92b33782-e97b-565d-b432-b19376ecedbc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5b1e27f9-71f0-5238-978b-5648b601e292","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2b6c5d09-7606-5742-89c4-19fa3b671fd7","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"037af05f-e510-5862-b316-4676f7c3a61e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"04bd9328-ed11-5b9d-ba9a-06584ecd6f33","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e183f01f-d538-542b-bc16-6f849966d1d2","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"b308cd54-8c76-53ac-a748-d71892ab0fd5","slug":"routine-infant-pneumococcal-vaccination","fullItemName":"Routine infant pneumococcal vaccination","depth":3,"htmlHeader":"<!-- begin field f561a47a-3abf-48aa-b78f-469e486fb935 --><h3>How should I routinely vaccinate infants against pneumococcal infection?</h3><!-- end field f561a47a-3abf-48aa-b78f-469e486fb935 -->","summary":null,"htmlStringContent":"<!-- begin item b7944312-93ed-4c36-847c-78326a6a173c --><!-- begin field 2ae19964-9969-4068-aee8-2ba50db3c530 --><ul><li><strong>Pneumococcal vaccine is a component of the routine infant immunization schedule — </strong>for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-childhood/\">Immunizations - childhood</a>.</li></ul><!-- end field 2ae19964-9969-4068-aee8-2ba50db3c530 --><!-- end item b7944312-93ed-4c36-847c-78326a6a173c -->","subChapters":[{"id":"400ea769-4328-5c3f-8c5b-1cef85b00765","slug":"basis-for-recommendation-cb9","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ae061caa-5507-46e1-a769-8f3464b58ed7 --><h4>Basis for recommendation</h4><!-- end field ae061caa-5507-46e1-a769-8f3464b58ed7 -->","summary":null,"htmlStringContent":"<!-- begin item cb9ea260-97f7-4963-af49-fa42d536e282 --><!-- begin field 9a0c3a84-01e4-484c-802e-cc03e60240f4 --><p>The recommendations on routine infant pneumococcal immunization are based on government policy as discussed in Chapter 25 of <em>Immunisation against infectious disease</em> (the 'Green Book'), published by the Department of Health [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013a</a>]. </p><!-- end field 9a0c3a84-01e4-484c-802e-cc03e60240f4 --><!-- end item cb9ea260-97f7-4963-af49-fa42d536e282 -->","subChapters":[]}]},{"id":"fd7c657c-f96e-5588-9f3d-4a94b75a1bd1","slug":"routine-pneumococcal-vaccination-of-people-aged-over-65-years","fullItemName":"Routine pneumococcal vaccination of people aged over 65 years","depth":3,"htmlHeader":"<!-- begin field 5dac2090-764b-4d69-8b65-9615bbe5711f --><h3>How should I routinely vaccinate people aged over 65 years against pneumococcal infection?</h3><!-- end field 5dac2090-764b-4d69-8b65-9615bbe5711f -->","summary":null,"htmlStringContent":"<!-- begin item 1e486278-3fdc-46d0-90d0-04883bb44641 --><!-- begin field 7ce0a83a-0203-45a8-ba47-78d144deb24e --><ul><li><strong>A single dose of the 23-valent pneumococcal polysaccharide vaccine (PPV23) (Pneumovax<sup>®</sup>) should be offered to people aged 65 years and over.</strong><ul><li>If the person presents without a reliable immunization history, it should be assumed that they have not been vaccinated.</li></ul></li></ul><!-- end field 7ce0a83a-0203-45a8-ba47-78d144deb24e --><!-- end item 1e486278-3fdc-46d0-90d0-04883bb44641 -->","subChapters":[{"id":"12e6b1c5-1a26-56d8-ba4c-469f71e6f1b9","slug":"basis-for-recommendation-20b","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field d35356bb-6cc5-4f13-845f-7144e6a201d0 --><h4>Basis for recommendation</h4><!-- end field d35356bb-6cc5-4f13-845f-7144e6a201d0 -->","summary":null,"htmlStringContent":"<!-- begin item 20bcbcd9-05ef-491c-939f-e92869d6ae70 --><!-- begin field d8cd9cd0-ea00-45fc-81b1-652783bd534d --><p>The recommendations on routine pneumococcal immunization of people aged over 65 years are based government policy as discussed in Chapter 25 of <em>Immunisation against infectious disease</em> (the 'Green Book'), published by the Department of Health [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013a</a>].</p><!-- end field d8cd9cd0-ea00-45fc-81b1-652783bd534d --><!-- end item 20bcbcd9-05ef-491c-939f-e92869d6ae70 -->","subChapters":[]}]},{"id":"19b3d9e3-e1af-5f4e-afaf-71e3f5232f34","slug":"what-advice-should-i-give","fullItemName":"What advice should i give?","depth":3,"htmlHeader":"<!-- begin field 99b98a88-61d9-4f9c-89f8-b7373db220fc --><h3>What advice should I give?</h3><!-- end field 99b98a88-61d9-4f9c-89f8-b7373db220fc -->","summary":null,"htmlStringContent":"<!-- begin item 5510b63e-a3da-40d9-92fe-b97d150dc141 --><!-- begin field 34a89812-9c08-4641-b79e-af6b94d3b563 --><ul><li><strong>Explain the benefits of vaccination to the person, or their parent or carer</strong><strong>, </strong>in particular that it helps prevent serious illness, including meningitis in young children. <ul><li>Information about <a href=\"https://www.nhs.uk/conditions/vaccinations/\" data-hyperlink-id=\"95848b2f-2229-4469-a059-aa5600c9bc5c\">vaccinations</a> (including vaccine safety, risks and benefits, and individual vaccines) is available on the NHS website, at <a data-hyperlink-id=\"19b9dd10-0e5c-40c0-9f14-a992012a9535\" href=\"http://www.nhs.uk/pages/home.aspx\">www.nhs.uk</a>.</li></ul></li><li><strong>Reassure that vaccinations are safe, and serious adverse effects are very rare.</strong> Pain, swelling, and reddening at the site of injection are most common and systemic adverse effects, should they occur, are usually limited to mild fever.</li><li><strong>If pain or fever is problematic after the person has been vaccinated, then paracetamol or ibuprofen may be used.</strong> For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a>.<ul><li>Paracetamol or ibuprofen should not be used to <em>prevent</em> fever following infant pneumococcal vaccinations.</li></ul></li><li><strong>Offer parents or carers written information,</strong> such as the Public Health England patient information leaflet <a data-hyperlink-id=\"03dbdb0d-4d57-41ce-959c-a992012a955c\" href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/448789/8584-what-to-expect-after-vaccination-2015-2P-A5-02-web.pdf\">What to expect after vaccinations</a>.</li></ul><!-- end field 34a89812-9c08-4641-b79e-af6b94d3b563 --><!-- end item 5510b63e-a3da-40d9-92fe-b97d150dc141 -->","subChapters":[{"id":"e6ce0cf1-8a2b-56d0-a1b8-4587c7e3166d","slug":"basis-for-recommendation-83f","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f53338a1-4595-443f-b9b6-64859d2f4f28 --><h4>Basis for recommendation</h4><!-- end field f53338a1-4595-443f-b9b6-64859d2f4f28 -->","summary":null,"htmlStringContent":"<!-- begin item 83fb5d89-f9f1-4e2f-a1e3-de44b54d76db --><!-- begin field ce3537a1-ea04-4f43-8a5e-c7a3f81d5528 --><p>The recommendations on advice to give about pneumococcal immunization are based on information in the chapter on vaccine safety and adverse effects following immunization in <em>Immunisation against infectious disease</em> (the 'Green Book') published by Public Health England (PHE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013b</a>] , and are pragmatic, based on what CKS considers to be good clinical practice.</p><h5>Explaining the benefits of vaccination</h5><ul><li>Many parents find the process of having their children immunized distressing. Explaining the benefits of vaccination and giving reassurance about the limited nature of any adverse effects should be helpful.</li></ul><h5>Using paracetamol or ibuprofen</h5><ul><li>CKS found no controlled trials on the efficacy of paracetamol or ibuprofen in reducing pain or fever following vaccination. As paracetamol and ibuprofen have been shown to reduce fever and pain in conditions such as the common cold and influenza [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">Eccles, 2006</a>], it can be reasonably extrapolated that they may be effective in relieving these symptoms on an 'as required' basis after vaccination. </li><li>PHE recommends that paracetamol or ibuprofen should not be given to <em>prevent</em> fever in children who receive pneumococcal vaccinations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013b</a>]. It states that there is no evidence that paracetamol or ibuprofen prevent febrile convulsions and that there is some evidence that they may lower antibody responses to some vaccines when given around the time of vaccination [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">Prymula et al, 2009</a>].</li></ul><!-- end field ce3537a1-ea04-4f43-8a5e-c7a3f81d5528 --><!-- end item 83fb5d89-f9f1-4e2f-a1e3-de44b54d76db -->","subChapters":[]}]},{"id":"2438bf33-72b6-57cd-bee0-fd693036d5ac","slug":"how-to-administer-the-vaccine","fullItemName":"How to administer the vaccine","depth":3,"htmlHeader":"<!-- begin field 44ad4d9c-89d8-4e4e-9941-f4eab818a253 --><h3>How should I administer the pneumococcal vaccine?</h3><!-- end field 44ad4d9c-89d8-4e4e-9941-f4eab818a253 -->","summary":null,"htmlStringContent":"<!-- begin item 4bf125cb-120d-4ec2-9b3b-03e553ff6b66 --><!-- begin field de29a48d-0958-4752-bbe8-7a3fdd78c325 --><ul><li><strong>Obtain written or verbal consent at the time of vaccination for people aged over 16 years.</strong><strong> For younger people it is usual to get consent from a person with parental responsibility.</strong><ul><li>Adults over 18 years of age are presumed to be competent to consent to treatment provided they can comprehend and retain the information they are given, and they can consider the facts and make an informed decision.</li></ul></li><li><strong>Ensure that:</strong> <ul><li>There are no contraindications to the vaccine.<ul><li>The only absolute contraindication to pneumococcal vaccination is a confirmed previous anaphylactic reaction to the vaccine or one of its components.</li></ul></li><li>The person, parent, or carer has been fully informed about the vaccine and the vaccination procedure.</li><li>Possible adverse reactions have been discussed and the person, parent, or carer is aware of how to manage them. </li><li>The vaccine is correct, has been stored appropriately, and has not expired. </li></ul><ul><li>The vaccination site has been washed with soap and water if it is visibly dirty. </li></ul></li><li><strong>For people who are acutely unwell (for example with a fever or acute infection), postpone pneumococcal immunization until they have fully recovered.</strong> Minor illness without fever or systemic upset is not a valid reason to postpone immunization.</li><li><strong>Pneumococcal vaccines are usually given by intramuscular (IM) injection,</strong> into the upper arm in children and adults, or the anterolateral thigh in infants under 1 year of age. However, if the person has a bleeding disorder, the vaccine should be given by deep subcutaneous (SC) injection to reduce the risk of bleeding. <ul><li>Use a 25mm 23-gauge (blue) or 25-gauge (orange) needle for IM administration in most infants, children, and adults.<ul><li>In pre-term or very small infants, use a 16mm needle for IM injection. </li><li>In larger adults, a longer length (such as 38mm) may be required.  </li></ul></li></ul></li><li><strong>Pneumococcal vaccines can be given at the same time as other vaccines.</strong> If an additional vaccine is required on the same day, use separate limbs if possible, or inject at sites at least 2.5 cm apart. </li><li><strong>Record the date of administration, vaccine and product name, batch number, expiry date, dose administered, and site of administration for each vaccine.</strong> </li><li><strong>Observe the person after vaccination to detect immediate adverse reactions.</strong> Ensure any bleeding has stopped and check for any symptoms of anaphylaxis before they leave.<ul><li>Anaphylaxis is extremely rare, and usually becomes apparent within minutes. By the time the site has been checked for bleeding and documentation has been completed, most reactions will have become apparent. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li></ul></li></ul><!-- end field de29a48d-0958-4752-bbe8-7a3fdd78c325 --><!-- end item 4bf125cb-120d-4ec2-9b3b-03e553ff6b66 -->","subChapters":[{"id":"4f2f961d-ef45-55e1-b568-acae99f8d7c5","slug":"basis-for-recommendation-28e","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field e14fa6f3-99e6-421d-b18a-04c14490b459 --><h4>Basis for recommendation</h4><!-- end field e14fa6f3-99e6-421d-b18a-04c14490b459 -->","summary":null,"htmlStringContent":"<!-- begin item 28e73403-cb09-43f4-bc98-471395743cbd --><!-- begin field 57fc5183-5cec-4eaf-8ef1-e67bf2f147c1 --><p>These recommendations are based on chapters in<em> Immunisation against infectious disease</em> (the 'Green Book') published by Public Health England (PHE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013c</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013d</a>], and what CKS considers to be good clinical practice.</p><h5>Obtaining consent</h5><ul><li>Consent for immunizations does not legally have to be in writing, but must be given voluntarily by a fully informed person who is able to make and communicate their decision. For children not competent to give or withhold consent, a person with parental responsibility can provide this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013c</a>].</li></ul><h5>Site of administration</h5><ul><li>The site of administration depends on the child's age [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013d</a>]:<ul><li>The anterolateral aspect of the thigh is appropriate in children aged less than 1 year as the deltoid muscle is not considered to be well-enough developed for intramuscular injection.</li><li>Over the age of 1 year, vaccines are routinely given into the deltoid muscle as it is convenient, providing easy access, and it reduces the risk of localized reactions, which are common when vaccines are given subcutaneously.</li><li>The gluteal muscle should be avoided. The needle may not penetrate through adipose tissue into the muscle, and this may cause a poor immunological response to the vaccine. In addition, there is a risk of damage to underlying structures such as the sciatic nerve.</li></ul></li></ul><!-- end field 57fc5183-5cec-4eaf-8ef1-e67bf2f147c1 --><!-- end item 28e73403-cb09-43f4-bc98-471395743cbd -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}